Biotech

All Articles

Vaccine and also Keytruda combo effective in squamous cell carcinoma

.Invulnerable gate inhibitors are actually the superheroes of cancer therapy. Medicines like Bristol...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Regeneron's Opdualag rival shows 57% reaction price

.Regeneron is actually back with lasting follow-up for its own LAG-3 inhibitor and also PD-1 inhibit...

AstraZeneca messages data on internal rivals to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early consider the performance of its in-house antibody-d...

iTeos- GSK's TIGIT star presents purposeful improvement

.After introducing a period 3 launch based upon beneficial midstage end results, iTeos as well as GS...

More collaborative FDA can accelerate rare disease R&ampD: document

.The FDA needs to be much more open as well as collective to unleash a rise in commendations of unco...

Zenas, MBX, Bicara scalp to Nasdaq in hot time for biotech IPOs

.It is actually an uncommonly occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and also B...

Atea's COVID antiviral neglects to stop hospitalizations in period 3

.Atea Pharmaceuticals' antiviral has stopped working an additional COVID-19 trial, however the biote...

Neurocrine's bid to spare mental illness prospect falls short

.Neurocrine Biosciences' schizophrenia system pivot has actually neglected. The biotech was actually...

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has created an overdue entrance to the radioligand party, paying 100 million euros ($ 110 th...